Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer
NCT01096394 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2015-12-10
Summary
RATIONALE: Collecting and storing samples of tumor tissue and ascites fluid from patients to test in the laboratory may help the study of cancer.
PURPOSE: This pre-clinical research study is collecting tissue samples and ascites fluid from patients with stage III or stage IV ovarian/primary peritoneal/fallopian tube epithelial cancer.
Conditions
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Celgene Corporation
collaborator INDUSTRY -
Vanderbilt University
lead OTHER
Principal Investigators
-
Dineo Khabele, MD · Vanderbilt-Ingram Cancer Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-11-30
- Primary Completion
- 2015-10-31
- Completion
- 2015-10-31
Countries
- United States
Study Locations
More Related Trials
-
Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer
NCT03691012 ·Status: UNKNOWN
-
Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00445549 ·Status: TERMINATED ·Phase: PHASE2
-
Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer
NCT03606486 ·Status: TERMINATED ·Phase: NA
-
The Culture of Ovarian Cancer Organoids and Drug Screening
NCT04768270 ·Status: UNKNOWN
-
Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
NCT00582205 ·Status: TERMINATED ·Phase: PHASE2
-
Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers
NCT00002538 ·Status: COMPLETED ·Phase: PHASE2
-
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT00801320 ·Status: COMPLETED ·Phase: NA
-
Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer
NCT03297489 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT02050009 ·Status: WITHDRAWN ·Phase: PHASE1
-
Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
NCT00897806 ·Status: TERMINATED
-
Blood Collection From People With Ovarian Cancer
NCT02063464 ·Status: COMPLETED
-
Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies
NCT03943316 ·Status: RECRUITING
-
Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases
NCT01048814 ·Status: COMPLETED
-
Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
NCT03949283 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
NCT00096239 ·Status: COMPLETED ·Phase: PHASE2
-
Tumor Microenvironment in Ovarian Cancer
NCT06272240 ·Status: RECRUITING
-
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
NCT04701645 ·Status: RECRUITING ·Phase: PHASE1
-
Risk of Ovarian Cancer in Patients With a Pelvic Mass
NCT00315692 ·Status: COMPLETED
-
Study Looking at Biomarkers in Ovarian Cancer
NCT03419689 ·Status: RECRUITING ·Phase: NA
-
Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT00331422 ·Status: TERMINATED ·Phase: PHASE2
-
Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT02316834 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Neoadjuvant Therapy for Ovarian Cancer
NCT01146795 ·Status: COMPLETED ·Phase: PHASE2
-
Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
NCT00026091 ·Status: COMPLETED ·Phase: PHASE2
-
EC17 for Intraoperative Imaging in Occult Ovarian Cancer
NCT02000778 ·Status: COMPLETED ·Phase: PHASE1
-
WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
NCT01144442 ·Status: TERMINATED ·Phase: NA